Membrane-stabilizing agent. Prepn: P. M. Vanhoof, P. M. Clarebout, BE 760018; eidem, US 3923813 (1971, 1975 both to Christiaens). Toxicological study: A. Georges et al., Arzneim.-Forsch. 23, 519 (1973). Pharmacokinetics: T. Kobari et al., Eur. J. Clin. Pharmacol. 26, 129 (1984). HPLC determn in plasma: T. Kobari et al., J. Chromatogr. 278, 220 (1983). Clinical studies: D. P. Zipes et al., Am. J. Cardiol. 40, 586 (1977); P. J. Troup, D. P. Zipes, Am. Heart J. 97, 322 (1979). Reviews: P. Danilo, ibid. 119; I. Stoel, S. F. Hagemeijer, Eur. Heart J. 1, 147 (1980).
Antiarrhythmic (class I).
Antiarrhythmic